Work

ABT-165 plus FOLFIRI versus bevacizumab plus FOLFIRI in patients with metastatic colorectal cancer (mCRC) previously treated with fluoropyrimidine/oxaliplatin and bevacizumab.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.4_suppl.tps720

Authors: Zev A. Wainberg, Lan Wang, Huibin Yue, Monica Motwani, Sreeneeranj Kasichayanula, Martha Elizabeth Blaney, Louie Naumovski, John H. Strickler

Institutions: University of California, Los Angeles, AbbVie (United States), Medivation, Inc. (United States), Duke Medical Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2913580651

Cites:

Cited by: 1

Related to: 10